“Evaluation of 1,5-Anhydroglucitol as a Biomarker for Type 2 Diabetes Mellitus in Patients without Overt Nephropathy” (2022) Brazilian Journal of Pharmaceutical Sciences, 57. doi:10.1590/s2175-97902020000419078.